Cowen Inc’s Bristol-Myers Squibb BMY Stock Holding History

Cowen Inc’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-16,200	Closed	-$755K	–	464
2019 Q1	$773K	Buy	+16,200	New	+$807K	0.08%	133
2018 Q2	–	Sell	-3,500	Closed	-$221K	–	498
2018 Q1	$221K	Buy	+3,500	New	+$225K	﹤0.01%	178
2017 Q4	–	Sell	-30,000	Closed	-$1.9M	–	297
2017 Q3	$1.9M	Buy	+30,000	New	+$1.75M	0.07%	97
2016 Q3	–	Sell	-8,000	Closed	-$514K	–	236
2016 Q2	$588K	Buy	+8,000	New	+$565K	0.04%	153
2015 Q3	–	Sell	-10,900	Closed	-$725K	–	278
2015 Q2	$725K	Buy	+10,900	New	+$718K	0.04%	181
2013 Q3	–	Sell	-82,838	Closed	-$3.7M	–	224
2013 Q2	$3.7M	Buy	+82,838	New	+$3.6M	0.37%	50

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Cowen Inc's BMY Position: Q2 2019 in Review

Cowen Inc sold out of Bristol-Myers Squibb (BMY) in Q2 2019, closing a stake of 16,200 shares — an estimated $755K sold.

Cowen Inc first reported a position in BMY in Q2 2013 and held it in 6 quarters. The position peaked at $3.7M in Q2 2013. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

Cowen Inc reported no remaining Bristol-Myers Squibb position as of Q2 2019 after selling out during the quarter.
Cowen Inc sold 16,200 Bristol-Myers Squibb shares in Q2 2019, an estimated $755K.
Cowen Inc first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 6 quarters.
Cowen Inc's Bristol-Myers Squibb position peaked at $3.7M in Q2 2013.
1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on Cowen Inc's 13F filing for Q2 2019, filed 14 Aug 2019.